Monitoring cell viability is essential for evaluating drug effects in biomedical research. Traditional assays often rely on destructive end-point measurements, limiting their ability to capture dynamic cellular responses. Scalable, non-destructive technologies that enable real-time analysis of cell viability are critical for advancing both efficacy and safety testing.
In this application note, you will explore:
- How CytoTronics’ electrical imaging platform captures real-time changes in cell proliferation and viability
- Multi-parametric data characterizing the response of lung adenocarcinoma cells to the chemotherapeutic drug Paclitaxel over time
- Comparisons between impedance-based results and traditional end-point cell viability assays in assessing Paclitaxel efficacy and dose response
Measuring chemotherapy response in human lung carcinoma cells.